טוען...
Atovaquone ameliorate gastrointestinal Toxoplasmosis complications in a pregnancy model
BACKGROUND: Toxoplasma is an important source of foodborne hospitalization with no safe and effective therapy against chronic or congenital Toxopalsmosis. Atovaquone is a drug of choice but not approved for use in congenital Toxoplasmosis. We hypothesized atovaquone to be safe and effective against...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
International Scientific Literature, Inc.
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3560658/ https://ncbi.nlm.nih.gov/pubmed/22936182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.883342 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|